Contributing Writer for The Prospect Lily Hutcheson reflects on her fall break in London for a freshman seminar.

What keeps some immune systems youthful and effective in warding off age-related diseases? In a new paper published in ...

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...

Charting the "dark matter" of the viral universe has implications not just for biotechnology—but potentially for battling the ...

Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical ...

We took a look around the SfN 2024 poster hall, picking our favorite posters and those we thought our audience would be most ...

The strategic shift will allow the firm to focus on advancing a newly announced in vivo gene-editing therapy candidate that's in preclinical development.

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Have we entered the golden age of plant engineering?

EDT Cathie Wood’s ARK Investment bought 47.8K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...

Project Cure CRC, the breakthrough research fund of the leading nonprofit Colorectal Cancer Alliance, has announced five new ...

Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.